
X
UniQure presses go on Huntington’s gene therapy trial
https://pharmaphorum.com/news/uniqure-presses-go-on-huntingtons-gene-therapy-trial/
BioSensics’ HDWear provides real-time motor function scores in Huntington’s patients.
First treatment approved for Huntington’s Disease in almost a decade.
SD-809 will be vital for Teva if approved.
FDA rejected drug earlier this year.
Teva enters the machine learning market.